Lantern Pharma Inc. (LTRN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 33.02M |
| Enterprise Value | 107.14M |
| P/E Ratio | -0.3 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -1.9 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.04 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -2.17 |
| Return On Equity | -4.56 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -17.1M |
| Net Income | -17.12M |
| Diluted EPS | -1.57 |
Balance Sheet
| Total Cash | 7.36M |
| Total Cash/Share | 0.59 |
| Total Debt | 39,715 |
| Total Debt/Equity | -0.01 |
| Current Ratio | 1.96 |
| Book Value Per Share | -0.26 |
Price History
| 52-Week Change | -86.14 |
| 52-Week High | 4.34 |
| 52-Week Low | 0.45 |
| Moving Average 50 Days | 1.07 |
| Moving Average 200 Days | 2.36 |
Statistics
| Average Volume | 245,664 |
| Shares Outstanding | 14.94M |
| % Held by Institutions | 23.23 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
